NCT03075241View on ClinicalTrials.gov

Z-Drugs for Sleep Disorders in Alzheimer's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
SleepSleep DisordersInsomniaAlzheimer's Disease
Interventions
DRUG

Zolpidem

Zolpidem tablets, 10mg, 10pm (before bedtime) for 14 nights

DRUG

Zoplicone

Zoplicone tablets, 7.5mg, 10pm (before bedtime) for 14 nights

DRUG

Placebo

Inactive or inert pill which will be used as a comparator

Trial Locations (1)

Unknown

Geriatric Medical Centre, Brasília

All Listed Sponsors
lead

Brasilia University Hospital

OTHER

NCT03075241 - Z-Drugs for Sleep Disorders in Alzheimer's Disease | Biotech Hunter | Biotech Hunter